- Home
- ISPO vs BRNS Comparison
ISPO vs BRNS Comparison
Compare ISPO & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- BRNS
- Stock Information
- Founded
- ISPO 2010
- BRNS 2016
- Country
- ISPO United States
- BRNS United Kingdom
- Employees
- ISPO N/A
- BRNS N/A
- Industry
- ISPO Blank Checks
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- ISPO Finance
- BRNS Health Care
- Exchange
- ISPO Nasdaq
- BRNS Nasdaq
- Market Cap
- ISPO 44.3M
- BRNS 48.3M
- IPO Year
- ISPO N/A
- BRNS 2021
- Fundamental
- Price
- ISPO $3.06
- BRNS $1.18
- Analyst Decision
- ISPO
- BRNS Strong Buy
- Analyst Count
- ISPO 0
- BRNS 1
- Target Price
- ISPO N/A
- BRNS $3.00
- AVG Volume (30 Days)
- ISPO 30.2K
- BRNS 31.0K
- Earning Date
- ISPO 08-12-2025
- BRNS 08-07-2025
- Dividend Yield
- ISPO N/A
- BRNS N/A
- EPS Growth
- ISPO N/A
- BRNS N/A
- EPS
- ISPO N/A
- BRNS N/A
- Revenue
- ISPO $261,225,000.00
- BRNS $14,969,000.00
- Revenue This Year
- ISPO N/A
- BRNS N/A
- Revenue Next Year
- ISPO $148.66
- BRNS N/A
- P/E Ratio
- ISPO N/A
- BRNS N/A
- Revenue Growth
- ISPO N/A
- BRNS 1766.46
- 52 Week Low
- ISPO $2.19
- BRNS $0.64
- 52 Week High
- ISPO $7.17
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- ISPO 51.97
- BRNS 46.00
- Support Level
- ISPO $2.85
- BRNS $1.10
- Resistance Level
- ISPO $3.18
- BRNS $1.24
- Average True Range (ATR)
- ISPO 0.22
- BRNS 0.14
- MACD
- ISPO 0.03
- BRNS -0.01
- Stochastic Oscillator
- ISPO 65.67
- BRNS 36.61
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.